Literature DB >> 14633599

Interference with transforming growth factor-beta/ Smad3 signaling results in accelerated healing of wounds in previously irradiated skin.

Kathleen C Flanders1, Christopher D Major, Alidad Arabshahi, Ekinadese E Aburime, Miya H Okada, Makiko Fujii, Timothy D Blalock, Gregory S Schultz, Anastasia Sowers, Mario A Anzano, James B Mitchell, Angelo Russo, Anita B Roberts.   

Abstract

Transforming growth factor (TGF)-beta regulates many aspects of wound repair including inflammation, chemotaxis, and deposition of extracellular matrix. We previously showed that epithelialization of incisional wounds is accelerated in mice null for Smad3, a key cytoplasmic mediator of TGF-beta signaling. Here, we investigated the effects of loss of Smad3 on healing of wounds in skin previously exposed to ionizing radiation, in which scarring fibrosis complicates healing. Cutaneous wounds made in Smad3-null mice 6 weeks after irradiation showed decreased wound widths, enhanced epithelialization, and reduced numbers of neutrophils and myofibroblasts compared to wounds in irradiated wild-type littermates. Differences in breaking strength of wild-type and Smad3-null wounds were not significant. As shown previously for neutrophils, chemotaxis of primary dermal fibroblasts to TGF-beta required Smad3, but differentiation of fibroblasts to myofibroblasts by TGF-beta was independent of Smad3. Previous irradiation-enhanced induction of connective tissue growth factor mRNA in wild-type, but not Smad3-null fibroblasts, suggested that this may contribute to the heightened scarring in irradiated wild-type skin as demonstrated by Picrosirius red staining. Overall, the data suggest that attenuation of Smad3 signaling might improve the healing of wounds in previously irradiated skin commensurate with an inhibition of fibrosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14633599      PMCID: PMC1892357          DOI: 10.1016/s0002-9440(10)63582-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

Review 1.  Functions of mammalian Smad genes as revealed by targeted gene disruption in mice.

Authors:  M Weinstein; X Yang; C Deng
Journal:  Cytokine Growth Factor Rev       Date:  2000 Mar-Jun       Impact factor: 7.638

2.  Identification of novel TGF-beta /Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach.

Authors:  F Verrecchia; M L Chu; A Mauviel
Journal:  J Biol Chem       Date:  2001-03-08       Impact factor: 5.157

3.  CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling.

Authors:  A Holmes; D J Abraham; S Sa; X Shiwen; C M Black; A Leask
Journal:  J Biol Chem       Date:  2001-01-04       Impact factor: 5.157

Review 4.  TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target?

Authors:  M Martin; J Lefaix; S Delanian
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-05-01       Impact factor: 7.038

5.  Transforming growth factors beta1, beta2, and beta3 and their receptors are differentially regulated during normal and impaired wound healing.

Authors:  S Frank; M Madlener; S Werner
Journal:  J Biol Chem       Date:  1996-04-26       Impact factor: 5.157

6.  Intestinal anastomosis healing in rat: collagen concentration and histochemical characterization by Picrosirius red staining and polarizing microscopy.

Authors:  M Y Rabau; A Hirshberg; Y Hiss; D Dayan
Journal:  Exp Mol Pathol       Date:  1995-06       Impact factor: 3.362

7.  Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response.

Authors:  G S Ashcroft; X Yang; A B Glick; M Weinstein; J L Letterio; D E Mizel; M Anzano; T Greenwell-Wild; S M Wahl; C Deng; A B Roberts
Journal:  Nat Cell Biol       Date:  1999-09       Impact factor: 28.824

8.  Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts.

Authors:  E Piek; W J Ju; J Heyer; D Escalante-Alcalde; C L Stewart; M Weinstein; C Deng; R Kucherlapati; E P Bottinger; A B Roberts
Journal:  J Biol Chem       Date:  2001-03-21       Impact factor: 5.157

9.  Is Smad3 a major player in signal transduction pathways leading to fibrogenesis?

Authors:  A B Roberts; E Piek; E P Böttinger; G Ashcroft; J B Mitchell; K C Flanders
Journal:  Chest       Date:  2001-07       Impact factor: 9.410

Review 10.  Connective tissue growth factor: what's in a name?

Authors:  E E Moussad; D R Brigstock
Journal:  Mol Genet Metab       Date:  2000 Sep-Oct       Impact factor: 4.797

View more
  54 in total

Review 1.  Modifying radiation damage.

Authors:  Kwanghee Kim; William H McBride
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

2.  Smad3 deficiency alters key structural elements of the extracellular matrix and mechanotransduction of wound closure.

Authors:  Praveen R Arany; Kathleen C Flanders; Tetsu Kobayashi; Catherine K Kuo; Christina Stuelten; Kartiki V Desai; Rocky Tuan; Stephen I Rennard; Anita B Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

Review 3.  Radiotherapy and wound healing.

Authors:  Emma-Louise Dormand; Paul E Banwell; Timothy E E Goodacre
Journal:  Int Wound J       Date:  2005-06       Impact factor: 3.315

4.  Nicotine inhibits myofibroblast differentiation in human gingival fibroblasts.

Authors:  Yiyu Fang; Kathy K H Svoboda
Journal:  J Cell Biochem       Date:  2005-08-15       Impact factor: 4.429

5.  Dermal transforming growth factor-beta responsiveness mediates wound contraction and epithelial closure.

Authors:  Magaly Martinez-Ferrer; Ali-Reza Afshar-Sherif; Consolate Uwamariya; Benoit de Crombrugghe; Jeffrey M Davidson; Neil A Bhowmick
Journal:  Am J Pathol       Date:  2009-12-03       Impact factor: 4.307

6.  Smad7 inhibits TGF-β1-induced MCP-1 upregulation through a MAPK/p38 pathway in rat peritoneal mesothelial cells.

Authors:  Xin Wang; Xiaoyan Li; Ling Ye; Weiying Chen; Xueqing Yu
Journal:  Int Urol Nephrol       Date:  2012-12-15       Impact factor: 2.370

7.  SMAD3 gene variant is a risk factor for recurrent surgery in patients with Crohn's disease.

Authors:  Sharyle A Fowler; Ashwin N Ananthakrishnan; Agnes Gardet; Christine R Stevens; Joshua R Korzenik; Bruce E Sands; Mark J Daly; Ramnik J Xavier; Vijay Yajnik
Journal:  J Crohns Colitis       Date:  2014-01-24       Impact factor: 9.071

8.  Fate-determining mechanisms in epithelial-myofibroblast transition: major inhibitory role for Smad3.

Authors:  András Masszi; Pam Speight; Emmanuel Charbonney; Monika Lodyga; Hiroyasu Nakano; Katalin Szászi; András Kapus
Journal:  J Cell Biol       Date:  2010-02-01       Impact factor: 10.539

9.  Ultrafast mid-IR laser scalpel: protein signals of the fundamental limits to minimally invasive surgery.

Authors:  Saeid Amini-Nik; Darren Kraemer; Michael L Cowan; Keith Gunaratne; Puviindran Nadesan; Benjamin A Alman; R J Dwayne Miller
Journal:  PLoS One       Date:  2010-09-28       Impact factor: 3.240

10.  Therapeutic improvement of scarring: mechanisms of scarless and scar-forming healing and approaches to the discovery of new treatments.

Authors:  Nick L Occleston; Anthony D Metcalfe; Adam Boanas; Nicholas J Burgoyne; Kerry Nield; Sharon O'Kane; Mark W J Ferguson
Journal:  Dermatol Res Pract       Date:  2010-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.